News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Vickers Philip J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
| 06/10/2022 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
| 05/13/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Bought 4,800 shares
@ $8.35, valued at
$40.1k
|
|
| 06/14/2021 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,438 options to buy
@ $9.63, valued at
$167.9k
|
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 14,000 options to buy
@ $21.91, valued at
$306.7k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2019 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 9,675 options to buy
@ $13.6, valued at
$131.6k
|
|
| 05/10/2019 |
4
| Vickers Philip J. (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 9,000 options to buy
@ $12.82, valued at
$115.4k
|
|
| 01/09/2019 |
4
| Vickers Philip J. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 18,743 options to buy
@ $15.78, valued at
$295.8k
|
|
| 01/09/2019 |
3
| Vickers Philip J. (Director) has filed a Form 3 on AVROBIO, Inc. |
| 05/11/2018 |
4
| Vickers Philip J. (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $29.15, valued at
$174.9k
|
|
| 03/16/2018 |
4
| Vickers Philip J. (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Bought 2,250 shares
@ $31.25, valued at
$70.3k
Bought 900 shares
@ $31.2, valued at
$28.1k
|
|
| 05/12/2017 |
4
| Vickers Philip J. (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $20.9, valued at
$125.4k
|
|
| 05/09/2016 |
4
| Vickers Philip J. (Director) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $16.63, valued at
$133k
|
|
|
|